Get the Daily Brief
Latest Biotech News
Emerging Therapeutics and Trial Innovations in Obesity Research
Obesity trials are evolving amid $30 billion global investment in 2024, focusing on complex endpoints and patient-centric designs. Sponsors emphasize integrating digital tools like eCOAs,...
Precision Oncology Enhanced by Integrated Biomarker Testing and CDx Development
Labcorp outlines strategic approaches to biomarker integration across oncology development, highlighting its role in patient stratification, trial acceleration, and regulatory streamlining. The...
Narcolepsy Drug Race Heats Up with Alkermes and Takeda Phase 2/3 Data
Alkermes and Takeda Pharmaceuticals reported encouraging data for their orexin agonist candidates targeting narcolepsy type 1. Alkermes’ Phase 2 trial of alixorexton showed significant increases...
Servier Acquires Kaerus Bioscience’s Fragile X Syndrome Candidate for Up to $450 Million
French pharmaceutical company Servier has entered an acquisition agreement with UK-based Kaerus Bioscience to obtain rights to KER-0193, an oral small molecule drug targeting fragile X syndrome....
First-in-Human Trial of DLL3-Targeted ADC SHR-4849 Shows Promise in Relapsed SCLC
SHR-4849, an antibody-drug conjugate (ADC) targeting Delta-like ligand 3 (DLL3), demonstrated encouraging results in its first-in-human Phase 1 trial for relapsed small cell lung cancer patients....
Advances in EGFR-Mutated NSCLC: Combination Therapies Extend Survival and Response
Recent clinical trials showcased at IASLC 2025 reveal breakthroughs in treating EGFR-mutated non-small cell lung cancer. The FLAURA2 study demonstrated that combining osimertinib and chemotherapy...
Ionis’ Olezarsen Phase III Data Drives Stock Surge on Hypertriglyceridemia Potential
Ionis Pharmaceuticals reported highly statistically significant Phase III results for olezarsen in severe hypertriglyceridemia, showing up to 72% triglyceride reduction and 85% decrease in acute...
Fentanyl-Hunter ML Platform Identifies Novel Opioid Metabolites for Overdose Prevention
A multidisciplinary team developed Fentanyl-Hunter, a machine learning-based platform that rapidly and accurately screens for fentanyl and its analog metabolites in biological and environmental...
Antibody-Drug Conjugates for Small Cell Lung Cancer Progress
Recent clinical trials have demonstrated promising efficacy of antibody-drug conjugates (ADCs) targeting DLL3 in aggressive small cell lung cancer (SCLC). Merck and Daiichi Sankyo's ADC showed...
Emerging Therapies in EGFR-Mutated Non-Small Cell Lung Cancer
Breakthrough clinical data presented at the IASLC 2025 conference reveal several promising therapeutic advances for EGFR-mutated non-small cell lung cancer (NSCLC). A bispecific antibody-drug...
CRISPR-Based Epigenetic Therapies Advance to Clinical Testing in China
Epigenic Therapeutics secured $60 million in Series B funding to accelerate clinical trials of its pioneering CRISPR-based epigenetic therapies targeting chronic hepatitis B. This approach...
Innovations in AI and Machine Learning for Drug and Disease Detection
Cutting-edge applications of artificial intelligence and machine learning are transforming biomedical detection and diagnostics. A novel platform named Fentanyl-Hunter employs machine learning to...
Advances in Immune and Inflammatory Biomarkers in Cancer and Cardiovascular Disease
Significant progress highlights the role of immune and inflammatory markers in predicting cancer and cardiovascular outcomes. A novel immune cell model utilizing multiplex immunofluorescence...
Breakthroughs in Cognitive and Neurological Research and Treatment
Recent studies deliver insights into neurological health and potential interventions. Prospekta, a novel compound, has shown cognitive enhancement in aging rat models simulating age-related...
Novel Bioengineering and Drug Delivery Technologies Emerge
Innovations in bioengineering are advancing drug delivery modalities. Researchers at Technical University of Munich developed multifunctional hollow microspheres comprising mucus and polydopamine...
Mitochondrial and Genetic Insights in Microorganisms and Evolution
Groundbreaking genomic research sheds light on evolutionary biology and host-microbe interactions. Complete mitochondrial genomes of Prototheca species were sequenced revealing comparative...
Gender and Sex Differences in Neurobiology and Disease Response
New research highlights sex-specific biological responses in neurological and physiological contexts. Studies reveal that microglial cells—the brain’s immune cells—exhibit sex-dependent stress...
Innovations and Challenges in Nursing and Healthcare Workforce Development
Recent studies address critical challenges in nursing and healthcare workforce dynamics. Ageism in nursing was effectively reduced through targeted educational interventions in a randomized...
Fentanyl-Hunter: Machine Learning Uncovers New Opioid Metabolites
Researchers from Shanghai University of Sport, Fudan University, and the Shanghai Institute for Doping Analysis have developed Fentanyl-Hunter, a machine learning platform to screen for fentanyl...
Phase 3 Trials Signal New Hope in NSCLC Treatment Using EGFR and DLL3 Strategies
Multiple recent clinical trials highlight promise in advanced non-small cell lung cancer (NSCLC) therapy. Ionis Pharmaceuticals disclosed statistically significant Phase 3 results for olezarsen,...